Form 4 Tracker
Mineralys Therapeutics, Inc.
MLYS

24 insider filings · Latest: Apr 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 13, 2026May 13 8:11 PMRodman David Malcom
Proposed Sale
14,056$28.58$401.8K

View →

May 12, 2026May 12 9:05 PMRodman David Malcom
Proposed Sale
6,348$29.36$186.3K

View →

May 11, 2026May 11 8:27 PMRodman David Malcom
Proposed Sale
2,171$29.71$64.5K

View →

Apr 17, 2026Apr 21 10:59 PMDavid Malcom RodmanChief Medical Officer
Sale
416$31.33$13.0K69,792(D)

View →

Apr 17, 2026Apr 17 8:17 PMRodman David Malcom
Proposed Sale
416$31.33$13.0K

View →

Apr 15, 2026Apr 16 1:45 AMDavid Malcom RodmanChief Medical Officer
Sale
6,348$27.66$175.6K69,792(D)

View →

Apr 13, 2026Apr 16 1:45 AMDavid Malcom RodmanChief Medical Officer
Sale
14,058$26.54$373.1K76,140(D)

View →

Apr 13, 2026Apr 16 1:45 AMJon CongletonDirector, Chief Executive Officer
Sale
15,730$26.83$422.0K689,321(D)

View →

Apr 15, 2026Apr 15 8:21 PMRodman David Malcom
Proposed Sale
6,348$27.66$175.6K

View →

Apr 9, 2026Apr 14 1:13 AMDavid Malcom RodmanChief Medical Officer
Sale
2,170$27.38$59.4K76,140(D)

View →

Apr 13, 2026Apr 13 8:22 PMCongleton Jon
Proposed Sale
15,730$26.83$422.0K

View →

Apr 13, 2026Apr 13 8:18 PMRodman David Malcom
Proposed Sale
14,058$26.54$373.1K

View →

Apr 9, 2026Apr 9 8:24 PMRodman David Malcom
Proposed Sale
2,170$27.38$59.4K

View →

Mar 31, 2026Apr 2 10:54 PMJon CongletonDirector, Chief Executive Officer
Sale
75,000$26.27$2.0M705,051(D)

View →

Mar 31, 2026Apr 2 10:53 PMDaphne KarydasDirector
Sale
3,000$25.00$75.0K6,200(D)

View →

Mar 31, 2026Mar 31 8:18 PMKarydas Daphne
Proposed Sale
3,000$25.00$75.0K

View →

Mar 31, 2026Mar 31 8:15 PMCongleton Jon
Proposed Sale
75,000$26.27$2.0M

View →

Mar 30, 2026Mar 31 8:15 PMRA CAPITAL MANAGEMENT, L.P.Director
Purchase
58,300$24.16$1.4M5,825,521(I)

View →

Mar 27, 2026Mar 31 8:15 PMRA CAPITAL MANAGEMENT, L.P.Director
Purchase
310,700$23.67$7.4M5,767,221(I)

View →

Mar 17, 2026Mar 17 9:04 PMRodman David Malcom
Proposed Sale
417$25.65$10.7K

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 17, 2026Feb 17 11:56 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
417$15.445,417(D)

View →

Feb 13, 2026Feb 14 12:25 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
7,707$14.25100,001(D)

View →

Feb 12, 2026Feb 14 12:25 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
6,349$1.0831,743(D)

View →

Feb 9, 2026Feb 11 11:58 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
2,171$16.0026,047(D)

View →

Jan 20, 2026Jan 21 1:33 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
416$15.445,834(D)

View →

← Previous

Page 2 of 2